Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?

  1. Alen, B.O.
  2. Estévez-Pérez, L.S.
  3. Hermida-Romero, M.T.
  4. Reguera-Arias, A.
  5. García-Campelo, R.
  6. de la Torre-Bravos, M.
  7. Concha, Á.
Journal:
Cancers

ISSN: 2072-6694

Year of publication: 2022

Volume: 14

Issue: 14

Type: Article

DOI: 10.3390/CANCERS14143323 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus